1.Effects of Celastrus orbiculatus extract on gastric organoids and expression of E -caherin in mice
Fangyuan Zhu ; Xiaoze Zhang ; Yanqing Liu ; Ping Li ; Yaodong Zhu
Acta Universitatis Medicinalis Anhui 2023;58(3):471-476
Objective:
To investigate the effect of Celastrus orbiculatus extract ( COE) on the growth of gastric organoids and the expression of E-cadherin in gastric epithelial cells of mice.
Methods:
The gastric pylorus of 8-week-old C57 mice was isolated and cultured into gastric organoids.The dynamic changes of gastric organoid formation were observed under light microscope ; the intercellular structure of gastric epithelium was observed by HE staining ; the expression of epithelial-cadherin E-cadherin in gastric epithelial cells was observed by immunofluorescence staining.After passage to the third-generation ,the organoids were treated with different concentrations of COE (0,5 ,10,20 μg/ ml) ,the organoids were collected ,their numbers were counted ,their diameters were measured,their cellular activities were measured by methyl thiazolyl tetrazolium( MTT) colorimetry,and Western blot was used to detect the expression of E-cadherin in organoids after COE treatment.
Results :
At 24 to 48 h, cystlike structures were formed and three-dimensional cell clusters with cystic gland-like central structure appeared, and gradually budding and forming gastric organoids after 72 h,suggesting that the organoids were successfully constructed.The epithelial cell marker E-cadherin was expressed in the organoid,which further confirmed the formation of organoid.Compared with the control group,the number and diameter of gastric organoids in the COE group significantly increased,cell activity was significantly enhanced (P<0. 05) ,and the expression of E-cadherin increased with the increase of COE dose (P<0. 01) .
Conclution
Low dose COE can promote the expression of E-cadherin and the growth and formation of organoids,which may affect the repair of gastric mucosa injury.
2.Hemophagocytic lymphohistiocytosis caused by tislelizumab
Anxia LI ; Shuyi XUE ; Bingqing ZHAO ; Yaodong PING
Adverse Drug Reactions Journal 2023;25(11):700-702
A 49-year-old male patient with primary hepatocellular carcinoma was treated with donafenib combined with tislelizumab. After 2 cycles of treatments, he developed persistent fever, poor appetite, fatigue, decreased white blood cells, hemoglobin, platelets, and fibrinogen, and significant increase of serum ferritin(91 501 μg/L) and splenomegaly. Hemophagocytic lymphohistiocytosis was diagnosed, which was consideredto be caused by tislelizumab. He received intravenous infusion of methylprednisolone 60 mg/d for 4 days, 40 mg/d for 7 days, 28 mg/d for 5 days, and at last, oral prednisone 35 mg/d was given, with dose reduction to discontinuation within 4-6 weeks. During the treatment, his laboratory tests results were improved. The patient did not use tislelizumab again and donafenib treatment was reused, and the above symptoms did not recur.
3.Hemophagocytic lymphohistiocytosis caused by tislelizumab
Anxia LI ; Shuyi XUE ; Bingqing ZHAO ; Yaodong PING
Adverse Drug Reactions Journal 2023;25(11):700-702
A 49-year-old male patient with primary hepatocellular carcinoma was treated with donafenib combined with tislelizumab. After 2 cycles of treatments, he developed persistent fever, poor appetite, fatigue, decreased white blood cells, hemoglobin, platelets, and fibrinogen, and significant increase of serum ferritin(91 501 μg/L) and splenomegaly. Hemophagocytic lymphohistiocytosis was diagnosed, which was consideredto be caused by tislelizumab. He received intravenous infusion of methylprednisolone 60 mg/d for 4 days, 40 mg/d for 7 days, 28 mg/d for 5 days, and at last, oral prednisone 35 mg/d was given, with dose reduction to discontinuation within 4-6 weeks. During the treatment, his laboratory tests results were improved. The patient did not use tislelizumab again and donafenib treatment was reused, and the above symptoms did not recur.
4.Cochlear implantation with pericanal electrode insertion technique.
Tingting CUI ; Hong JIANG ; Xiaowei CHEN ; Guodong FENG ; Zhiyong ZHANG ; Fengrong LI ; Cuixia ZHAO ; Zhiqiang GAO ; Dongyi HAN ; Shiming YANG ; Pu DAI ; Jianan LI ; Xin XI ; Xiulan MA ; Yaodong DONG ; Ping YU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2011;25(10):457-459
OBJECTIVE:
To investigate the surgical technique of the pericanal electrode insertion technique for ies cochlear implantation.
METHOD:
Forty cases of sensorineural deafness were subjected to the ies cochlear implants. Cochleostomy was performed through the external auditory canal with a microdrill anterior to the round window. The electrode impedance and electrically auditory brainstem responses(EABR) were tested during the operation. The X-ray photographs were taken after the operation. The cochlear implant was activated in all 40 cases 4 weeks following surgery.
RESULT:
All of the electrodes were inserted and all of the implants worked well. No electrode extrusions or serious surgical complications happened during postoperative observation for 6 months.
CONCLUSION
The pericanal electrode insertion technique is a safe approach for ies cochlear implantation.
Child, Preschool
;
Cochlear Implantation
;
methods
;
Cochlear Implants
;
Ear Canal
;
surgery
;
Female
;
Hearing Loss, Sensorineural
;
surgery
;
Humans
;
Infant
;
Male
;
Otologic Surgical Procedures
;
methods
;
Subcutaneous Tissue
;
surgery
5.Construction of the prokaryotic expression system for the prtC gene of Porphyromonas gingivalis and analysis of the relationship between thelocal level of PrtC protein and the periodontal damage
Ping RUAN ; Yaodong LUO ; Jie YAN
Chinese Journal of Zoonoses 2005;(5):369-374
Porphyromonas gingivalis is a specific causative agent of human chronic periodontitis. This anaerobe produce collagenase PrtC encoded by prtC. To constructed the prokaryotic expression system for the prtC gene from P.gingivalis so as to be used to explore antigenicity and immunoreactivity of prtC gene product as well as the relationship between the local level of PrtC and the periodontitis damage, the entire length of prtC genes fragment from the ATCC-33277 and 47A-1 strains of P.gingivalis was amplified by PCR. After T-A cloning and sequencing, the prokaryotic expression system for prtC was constructed by using pET32a plasmid and E.coli BL21DE3 strain. The expression of the target recombinant PrtC protein was induce with different concentrations of IPTG. Western blot assay was used to detect the antigenicity and immunoreactivity of PrtC protein, and ELISA assay was used to detect the PrtC level in the subgingival plaque samples of patients with chronic periodontitis. The experimental results showed that the nucleotide sequences of the prtC genes from ATCC-33277 and 47A-1 strains of P.gingivalis were entirely identical, and the sequence similarities of nucleotides and amino acids were 98.46% and 99.07% respectively. Under the induction of different concentration of IPTG, the output of recombinant expressed product PrtC may reach up to 50% of the total bacterial proteins. It was also proved that the recombinant PrtC could bind with antibody against the whole cell of P.gingivalis, and could induce the production of specific antibodies in rabbit. In 91.39% of the subgingival plaque samples, the PrtC could be detectable, in which the level of positive rates of detection was higher in severe cases of chronic periodontitis than that in the mild cases. So far, a prokaryotic expression system for the prtC gene from P.gingivalis with high expression efficiency was successfully constructed in the present study, and the expressed product PrtC possesses well antigenicity and immunoreactivity, suggesting the possibility to be used as the candidate antigen for developing the serological kit and P.gingivalis vaccine.


Result Analysis
Print
Save
E-mail